SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richaaard who wrote (1009)3/29/1999 9:20:00 PM
From: Doug Bean  Read Replies (1) of 1837
 
Richard: I agree with your first message and am not quite in agreement with your last one. it is true that women complain about premarin. but doctors will be loathe to switch prescriptions due to potential lawsuits etc. In premarin they have a known evil,, it works and the side effects are relatively minor. While i believe cenestin is a better product and will have less side effects. They will not want to easily take the chance that there could be something that comes up. They would rather have women complain than risk a lawsuit. This way they won't be sued,, the other there is at least a small potential. Can you imagine a lawyer in court saying "and why did you switch prescriptions when you knew for sure that the original drug would not cause this problem. etc etc. anyway i do agree that if DRMD makes the right connection with a well thought of "distrubutor " who has a large sales force,, there willbe a bump up in the stock and shortly there after there will be large sales news which will cause the stock to climb as rapidly as the news can be updated. If they do hit the 100,000,000 a year sales rate,,, you can't put enough value on the stock. i am buying again, i bought today and had another order go unfilled. i will be back at it tomorrow. CRDoug
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News